|
|
Media partners 
We work with leading magazines and publishers in this arena. If you are interested in becoming a media partner for this event please contact: Julie Phillips, Marketing Manager
Email: julie.phillips@terrapinn.com Tel: 02075394336 Fax: 02072421508
|

Genetic Engineering and Biotechnology News (GEN) is the longest-running, most widely read, and largest circulated global biotechnology news publication. Published 21 times a year and recently redesigned to focus on Biobusiness, OMICS, Drug Discovery, Bioprocessing, and Translational Medicine, GEN reports on key news developments and technology trends in the bioindustry.

Biopharm International is the #1 magazine devoted to the science, strategies and business trends shaping the global landscape for biotherapeutics. Biopharm's focus on applied technologies utilized in biopharmaceutical development and its focus on the business forces driving the industry's growth has attracted a BPA-qualified, global audience of 29,200.

Bentham Science Publishers, a major STM journal publisher of over 70 titles in 2006, answers the information needs of the pharmaceutical, bio and medical research community. Leading journals include Current Pharmaceutical Design (Impact Factor 5.38):
FREE online journals and information: www.bentham.org
Subscribe, Consortia, discounted global licenses and trials: subscriptions@bentham.org

Thomson Pharma was developed to help pharmaceutical companies make better decisions faster.
It integrates information from Thomson Scientific with information from other Thomson sources, including the Financial, Healthcare and Legal and Regulatory groups. Thomson Pharma's core content areas include drug information, intellectual property data, literature and news, company data, chemical information, sequence data and drug target information, enhanced with value added content resources and powerful search tools. www.thomsonpharma.com

SCREENING - Trends in Drugs Discovery focuses new trends and developments in drug discovery. SCREENING covers all aspects of research as well as strategies of pharmaceutical companies and start-up companies. This editorial mixture makes for relevant reading for all those concerned with drug discovery. SCREENING - Trends in Drugs Discovery is published in English with 4 editions in 2006. For more information please contact Dr. Jutta van Empel at j.empel@gitverlag.com or tel. +49 6151 8090-139.

Generics bulletin is the global generic industry’s essential source of news and views on product launches, company deals, regulatory changes and patent pricing and reimbursement issues. Two formats: a weekly electronic newsflash and a twice-monthly paper publication provide both immediacy and depth from a generics industry perspective. For further information please visit www.generics-bulletin.com or contact Val Davis at val.davis@generics-bulletin.com or call +44 (0)1564 777550.

Piribo is the source for information products for the global biotechnology, healthcare and pharmaceutical industries.
Use Piribo to browse thousands of business information studies, market reports and books. Find the research you need in your work

JGM is the major, international business journal which covers all aspects of business development, regulatory affairs, manufacturing and marketing affecting the generic pharmaceutical industry. Each quarterly issue publishes analyses, briefings and updates which are of direct relevance to the generics and related industries.




Focusing on key strategic insights, in-depth interviews, quick fire Q&A, as well as regular contributions from senior leaders in pharmaceutical manufacturing, this bi-monthly publication is sent to a readership of over 13,000 European professionals. This forward thinking digital publication has a flexible, interactive and user friendly format, allowing readers to access the magazine anytime, anywhere. For more information, contact Simon Percival on T/ +44 (0) 1244 393426, email spercival@advanstar.com or visit our website: www.ptemagazine.com

Pharmaceutical Executive Europe magazine is the leading strategy-based, business management publication for senior executives, corporate strategists and sales & marketing leaders in the European pharmaceutical industry.
Tackling strategic business and marketing issues, Pharm Exec Europe provides complete high-quality analysis, opinion and industry news on critical trends and developments; sales and marketing strategies; corporate policy, management and branding; research and development; legislation; finance; new technologies and much more.
Pharm Exec Europe is the indispensable read for senior pharmaceutical executives who need to stay informed, innovative and ahead of the game.

Bentham Science Publishers, a major STM journal publisher of 79 titles in 2007, answers the information needs of the pharmaceutical, bio and medical research community. Leading journals include Current Drug Metabolism (Impact Factor 5.4) and Current Pharmaceutical Design (Impact Factor 4.8) :
*FREE online journals and information: www.bentham.org
*Subscribe, Consortia, discounted global licenses and trials: subscriptions@bentham.org

Outsourcing-pharma.com is the leading B2B online strategic news resource for the pharmaceutical industry, enabling industry professionals and key decision makers to keep ahead of breaking news worldwide. Outsourcingpharma.com provides a strong platform of communication for industry professionals, encompassing bespoke marketing strategies to compliment your company’s business objectives.

BioPharmareporter.com is the leading B2B strategic news resource for the biopharmaceutical market, providing key decision makers and industry professionals with the crucial market intelligence and latest breaking news across Europe, America and Asia Pacific. Subscribe now for the FREE e-newsletter of this complete information source within the pharmaceutical industry.

In-PharmaTechnologist.com provides professionals in the industry every day with the latest breaking news on technology and its implications for pharmaceutical manufacturing. This leading online publication allows its readers to focus clearly on the news that affects them and helps drive their business decisions. Join our subscriber base and receive your FREE newsletter now!
|
|
|
|